NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Edmond de Rothschild Investment Partners’

25 March 2014

Axonics raises $32.6m in Edmond de Rothschild-led Series A

medical monitor Edmond de Rothschild Investment Partners has led a $32.6m Series A funding round for Axonics Modulation Technologies, which is focused on developing implantable neuromodulation technology.

10 January 2014

Edmond de Rothschild appoints a new partner to life science VC arm

The Edmond de Rothschild Group has named Dr Naveed Siddiqi as a partner in its BioDiscovery venture capital funds franchise.

10 December 2013

Gimv leads €34m Series B investment in preclinical biotech developer Covagen

Belgium-based investment firm Gimv has led a €34m tranched Series B financing round for preclinical-stage biotech company Covagen, one of the largest private financing rounds of its kind.

4 November 2013

Edmond de Rothschild closes latest life sciences fund on €192m

biotech_lrg Edmond de Rothschild Investment Partners (EdRIP) has closed its BioDiscovery 4 venture capital fund on €192m, making it 25 per cent larger than its previous vehicle.

12 September 2013

Edmond de Rothschild Capital Partners managing partners de Montgolfier and Fouque resign

French firm Edmond de Rothschild Capital Partners announced that its managing partners Eric de Montgolfier and Erick Fouque have decided to step down.

19 August 2013

Gimv exits Endosense to St.Jude Medical

Private equity firm Gimv has exited its portfolio company Endosense to St.Jude Medical in a deal that could value the medical technology business at up to CHF309m.

16 August 2013

Edmond de Rothschild Investment Partners raises €192m for life sciences fund

French private equity firm Edmond de Rothschild Investment Partners has closed its fourth life sciences fund, BioDiscovery 4, on €192m.

23 July 2013

German medical device company JenaValve Technology inks $62.5m investment

German medical device company JenaValve Technology has raised $62.5m in a Series C venture round led by Belgium-based investment firm Gimv, alongside new investors including Beijing-based Legend Capital and healthcare-focused Omega Funds.

8 July 2013

OncoEthix raises $19m in SV Life Sciences-led Series B

Venture capital firm SV Life Sciences has led a CHF18m ($19m) Series B round for Swiss oncology drug development company OncoEthix.

3 June 2013

Edmond de Rothschild takes minority stake in conference producer MCI

French private equity firm Edmond de Rothschild Investment Partners has taken a minority stake in conference and events company MCI.

Page 1 of 212

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014